D-66373-001 Class III Terminated
FDA drug recall D-66373-001 was initiated by Sandoz Incorporated on September 25, 2013 and is designated Class III. Reason for recall: Failed Tablet/Capsule Specifications: Sandoz is recalling one lot of Hydroxychloroquine Sulfate Tablets, USP, 200mg, due to illegibility of the logo on some tablets. The recall status is terminated (terminated July 16, 2014). Affected quantity: 25,830 bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- October 16, 2013
- Initiation Date
- September 25, 2013
- Termination Date
- July 16, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 25,830 bottles
Product Description
Hydroxychloroquine Sulfate Tablets, USP, 200 mg, Rx Only, 100 Tablets per bottle, Sandoz Inc., Princeton NJ, 08540, NDC 0781-1407-01.
Reason for Recall
Failed Tablet/Capsule Specifications: Sandoz is recalling one lot of Hydroxychloroquine Sulfate Tablets, USP, 200mg, due to illegibility of the logo on some tablets.
Distribution Pattern
Nationwide
Code Information
Lot #: BU3417, Exp 06/2014